TSHA Operating Cash Flow (Statement)
Taysha Gene Therapies Inc · Operating Cash Flow (Statement)
TSHA Operating Cash Flow (Statement)
Latest reported-$132.19Mperiod ending
TSHA TTM Cash from Operations (-$10.88M → -$132.19M)
TTM operating cash flow (statement)
High-resolution chart · PNG
TSHA operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -132,191,000 | |
| -111,948,000 | |
| -93,090,000 | |
| -84,676,000 | |
| -82,125,000 | |
| -83,447,000 | |
| -81,225,000 | |
| -79,034,000 | |
| -75,368,000 | |
| -72,631,000 | |
| -73,018,000 | |
| -42,624,000 | |
| -53,485,000 | |
| -68,071,000 | |
| -88,825,000 | |
| -143,360,000 | |
| -146,483,000 | |
| -135,946,000 | |
| -117,042,000 | |
| -96,632,000 | |
| -71,415,000 | |
| -51,065,000 | |
| -30,729,000 | |
| -10,881,000 |